Watch Ticker

Imunon, Inc. Common Stock

Go to Imunon, Inc. Common Stock Website

$1.40

(%)

Live

Previous Close

$1.4

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$13.2 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harne...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Imunon, Inc. - Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting

LAWRENCEVILLE, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces that an abstract describing a Phase 2 study with IMNN-001 plus bevacizumab (Avastin®) and neoadjuvant chemotherapy in advanced epithelial ovarian cancer patients has been accepted for presentation at the American Society of Clinical Oncology (ASCO) annual meeting, to be held in Chicago from May 31st to June 4th.

Related tickers: IMNN.

Read Full Article

Imunon, Inc. - IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update

Conference Call Begins Today at 11:00 a.m. Eastern Time

Related tickers: IMNN.

Read Full Article

Trending Tickers

CTMX

XNAS

$1.89

(%)

MIMO

XASE

$0.11

(%)

PRSO

XNAS

$1.38

(%)

QQQ

XNAS

$451.76

(%)

FDXTF

$0.00

(%)